Building Bridges 2026 happening in:
0 Jours
0 Heures
0 Minutes
0 Secondes
Apprendre encore plus

HeroSupport SA

Contacter l'organisateur

Veuillez noter que le contenu de ce formulaire de contact est soumis à modération. Si l'organisation choisit de répondre, toute correspondance ultérieure se fera directement entre vos adresses électroniques respectives et ne sera pas soumise à la modération via ce site.

Veuillez cocher la case pour prouver que vous êtes un humain.

Assurez-vous d'utiliser la dernière version ou une version antérieure d'Internet Explorer/Edge, Chrome, Firefox ou Safari.
Le test de sécurité captcha a expiré, veuillez réessayer.
Une erreur s'est produite lors de la vérification du captcha de sécurité, veuillez réessayer.

Support mammaire personnalisé imprimé en 3D pour la radiothérapie.

VENUS SHELL™ is the first and only 3D-printed immobilization device for breast CE marked that helps to treat breast cancer in prone position, faster (minimum 30%) and more effectively. The model is created for each patient via a patented imaging table, using body images acquired via a surface scanner, modeled via our proprietary software, then 3D-printed for use.

Business model description: Target customers: hospitals and clinics, reached through distributors and industrial partners. The primary market is the US, where prone radiotherapy is more common and VENUS SHELL™ fully reimbursed. Other markets include Europe, Switzerland, and Middle East.

Themes: Tech-enabled Solutions | Health | Circular Economy

Regions/Countries of activity or interest: United States of America, Switzerland, Europe, Middle-East

Siège social de l'organisation: Suisse

Phase de levée de fonds: Série A

Modèle commercial: B2B

Fundraising Capital type: Equity, Grant, Debt



The information presented on this page has been provided by the participating organisation. Building Bridges publishes this information for general informational purposes only in connection with Building Bridges 2026. Building Bridges has not independently verified the information and does not endorse, recommend or make any representation regarding any organisation, product, service, strategy, investment opportunity or claim described herein. The participating organisation is responsible for the accuracy, completeness and regulatory compliance of the information it provides.